DermTopic: Acne

Filter Your Results

 

News

 

Almirall’s Seysara Set to Shake Up US Acne Market

The US Food and Drug Administration’s approval of Almirall’s Seysara (sarecycline) for the treatment of infl…

Study: Positive Safety and Tolerability Results for Ortho De…

Ortho Dermatologics shared results of two identical Phase 3, multicenter, randomized, double-blind, vehicle-controlled, …

Pre-conditioning Added to Sebacia Microparticles Enhances Ou…

Using pre-conditioning in conjunction with Sebacia Microparticles for treatment of acne leads to enhanced outcomes, new …

DermWireTV: FDA Approvals, Acne Insights, EPI Gets Cloderm

In a flurry of approvals, FDA gives the nod to Almirall's Seysara (sarecycline), Ortho Dermatologics' Bryhali (halobeta…

DermWire.com

Acne Stigma Linked to Lower Overall Q of L

Acne patients perceived social stigma negatively affects their quality of life, according to a new study from the Univer…

Is Teen Acne a Sign of Future Financial Success?

The love of books, the need for glasses and high intelligence are traits found among the top earners in many fields acro…

Seysara: Oral Antibiotic is First Approved for Dermatology i…

Seysara (sarecycline), a new, first in class tetracycline-derived oral antibiotic, is now approved for the treatment of …

Bellus Medical Now Part of Crown Laboratories

Crown Laboratories, Inc. and Hildred Capital Partners, LLC have acquired Bellus Medical. Bellus’s non-invasive …

 
 

Contact Info

For advertising rates and opportunities:
Rick Ehrlich
Group Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.